Anthropic and the Bill and Melinda Gates Foundation announced a $200 million partnership on Thursday that will deploy Claude across global health, education, and agriculture in low- and middle-income countries over the next four years.

The deal is four times larger than OpenAI's $50 million Horizon 1000 partnership with the same foundation, announced in January. That earlier deal pledged funding and technology for 1,000 healthcare clinics in African countries by 2028. Anthropic's commitment goes wider: vaccines, drug screening, agricultural AI for farmers, and literacy apps in sub-Saharan Africa and India.

What the Money Buys

Half the commitment comes from the Gates Foundation in grant funding and program design. The other half comes from Anthropic in the form of Claude usage credits, technical staff, and engineering support, Reuters reported, citing unnamed officials.

The health investment is the largest piece. Anthropic will work with the Gates Foundation to accelerate vaccine and therapy development for high-burden and neglected diseases, starting with polio, HPV, and eclampsia/preeclampsia. Claude will be used to screen potential drug and vaccine candidates computationally before they enter pre-clinical development. HPV alone causes roughly 350,000 deaths annually, according to the WHO, with 90% in low- and middle-income countries.

The partnership also targets health intelligence: Claude connectors, benchmarks, and evaluation frameworks that let researchers and governments understand how AI performs on healthcare tasks. Anthropic and the Gates Foundation will engage health ministries on workforce deployment, supply chain management, and outbreak detection.

Beyond health, the partnership includes education AI (student performance tools in the U.S., sub-Saharan Africa, and India, including literacy apps) and agriculture-specific Claude improvements that give farmers personalized, timely guidance on planting decisions.

Why This Matters More Than the Number

Anthropic is currently locked in a public feud with the Trump administration. CEO Dario Amodei published a blog post in February opposing the Defense Department's use of Anthropic technology for mass surveillance and autonomous weapons. Trump called Anthropic a "radical left, woke company" on Truth Social the next day and ordered federal agencies to stop using its products. The Pentagon's CTO Emil Michael still considers Anthropic a national security risk, though Politico reported in late April that the administration is quietly trying to forge a "ceasefire."

The Gates partnership is strategic positioning as much as philanthropy. While OpenAI signed a defense deal with the Pentagon and is preparing a $1 trillion IPO, Anthropic is building credibility with the world's most influential non-military institution. The Gates Foundation spent $8.3 billion in 2024 alone. Getting its endorsement is not a small thing.

It also fits a pattern: Anthropic has been outpacing OpenAI in business adoption (34.4% vs 32.3%, per the latest Ramp AI Index), and is reportedly raising $30 to $50 billion at a $950 billion valuation. Signing a $200 million deal with the world's largest private foundation while your competitor signed a $50 million one four months earlier is a power move with a spreadsheet attached.

The deal targets roughly 4.6 billion people who currently lack access to essential health services, according to Health Policy Watch. That is the addressable market for AI that actually matters.

First reported by Reuters and Forbes. Anthropic published its own announcement on May 14.